Charfty reglstratlon number 109094
Company reglstratlon numbor N1685604 (Northern Ireland)
PULMONARY FIBROSIS NI
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

PULMONARY FIBROSIS NI
LEGALAND ADMINISTRATIVE INFORMATION
Trustees
T J Mcmillan
J M Byrne
M U M¢Millan
P M Gorman
I Simpson
Dr. N Chaudhuri
C J Donohoe
(Appointed 26 June 2023}
(Appointed 16 June 20231
Charity number
109094
Company numbor
N1685604
Reglstered office
3 Chur¢hfield Road
BallycastEe
Northern Ireland
BT54 6PJ
Independent exan71ner
MTS Prior Mcmahon
104-108 Fran￿$ Street
Newtownards
Down
BT23 7DY

PULMONARY FIBROSIS NI
CONTENTS
Page
Trustees, report
Independent examineV$ Trport
Statement of financial activities
Balan￿ stieet
Notes to the financial statements
8-14

PULMONARY FIBROSIS NI
TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORT)
FOR THE YEAR ENDED 29 FEBRUARY 2024
The trustees present their annual report and finaneAal statements for the year ended 29 February 2024.
The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the
financial sl8tements and comply with the ¢hariVs Igoverr¢ing do¢ument], the Companies Act 2006 and "Accounting
and Reporting by Charities-. Statement of Recommended Practrce applicable to charities preparing their accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102}"
(effective 1 January 2019).
Constitution & Purpose
Pulmonary Fibrosis Nl IPFNI} is a charity govemed by a COnsti￿tion & recognised as a Private Limited
Company by guarantee without share capital use of 'Limited' by Companies House, incorporated 8 February
2022.. Company No. N1685604. Charity Number 109094.
It is managed by the trustees. Trustees are appointed by inwtation & agreernent of the Trustee5 at the AGM or an
Extraordinary General Meeting. Trustees may hold office for a maximum of 2 yeais before re-appointment is
requiied unless they resign or are removed from office by a resolution of the other trustees at the AGM or an
Extraordinary General Meeting.
PFNI primarily seeks to benefit the Northern Ireland community through its activities which aim to provide support
and relief for people living with Pulmonary Fibmsis and other Interstitial Lung Diseases in Northern Ireland and to
advan￿ education about Pulmonary Fibrosis and other Intersb'tial Lung Diseasés.
Publlc Beneflt
The public benefits that ffow from this purpose are lo-
foster an abnosphere of mutual support and encouragement among people suffering from Pulmonary
Fibrosis and other Interstitial Lung Diseases {PF} and their earer5. family and friends;
raise awareness for the benefit of the public about the effects of Pulmonary Fibrosis and other Interstitial
Lung Diseases and methods of management of such disease..
raise awareness for the benefit of the public about the effects of PulmorFary Fibrosis and other Interstrtial
Lung Diseases and methods of management of such disease.,
a. promote and raise awareness of the Organ Donor Register for the benefit of the publi
The beneficiaries of thi5 purpose are people living in Northern Ireland who have been diagnosed with
pulmonary fibrosis and other interstitial lung diseases. their families. friends, colleagues. and the general public
at large.
The direct benefits flowing from this purpose include improved mentsl health and reduced levels of stress and
anxiety eXperIen￿d by our beneficiaries & an increase in their knowledge of how to live well with their condition.
These benefits are emdenced through feedba¢k from beneficiaries at appropriate intervals. A private benefit
owing from this purpose is the experieno and knowledge members receive. However, this is incidental and
necessary as it is essential to ensure the benefit is promded to our beneficiar¢es. A private benefit is also gained
by suppliers who receive payments for goods and servI￿S provided. The benefit is incidental and necessary lo
ensure that benefit is provrded to our beneficiaries. Any expenses paid to TnJstee$ 15 reimbursement for
expense5 necessarily incurred in pursuit of the aims of the charity or of purchases made on behalf of the charity.

PULMONARY FIBROSIS NI
TRUSTEES. REPORT {INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUAR Y 2024
The purposes of our charity may lead to the following risks..
a. Trips and falls when beneficiarFes are using:
Puffin Lodge lour respite ¢aravan}. This facility is unsuitable for people who use wheelchairs or
mobility scooters Dr who a￿ unable to negotiate stairs. Site limitations are highlighted to applicants
and mobility is assessed duang the application process.
Events venues. Venues etc are assessed and chosen to ensure that the majority of our beneficiaries
can attend & use safely and comft)rtably.
b. Some beneficiaries require oxygen (021 which can be delivered to Puffin Lodge by BOC Ltd. The risks to
beneficiaries associated with 02 include..
non-delivery by BOC {note- timely ordering of 02 for delivery to & use at Puffin Lodge is the
responsibility of the beneficiary & they will contact BOC if this occurs)..
The equipment required to meet the 02 requirements of the beneficiary would generate noise
levels that are actsptable to other site users.
Oxygen needs a￿ discussed with the applicant and assessed during the application process. Unfortunately Puffin
Lodge. due lo its location and construction, cannot facilitate the needs of all our beneficiaiies.
02 needs of beneficiaries are considered when organising events to ensure. as far as reasonably
practicable. that the majority of benafictaries attend.
The potential of any such harm or risk arising is ou￿elghed by the benefit provided to the public.
The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activtties the
charity should undertake.

PULMONARY FIBROSIS NI
TRUSTEES. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY 2024
Revi9w of Publlc BenefitActivities In 2023124
PFNI continued to develop their activilies to reach and serve people with Pulmonary Fibrosi$ IPF), their carers and
families. and increase awareness of PF wthin the community at large.
Puffin Lodge, our respite static caravan in Ballycaslle was officially opened on 30 March 2023 by Robin Swann,
MLA and ft)mier Health Minister and Pat Goman, ILD Specialist Nu￿e at Antrim Area Hospital & 2022 Patients
Choice Nurse of the Year. Throughout the year {Mar-Novl Puffin Lodge was well Ltsed by families to have a much
needed break from home.- it also hosted fundraising coffee mornings which welcomed other Caravan owners and the
general public and opened conversations aboLrt the work of PFNI.
Further public benefit activities included=
Production of a comprehensive infom)ation pack that clinicians give to their patients on diagnosis or ¢an be
requested from PFNI directly. These were developed in co118boration with specialist PF dinicians.
b. Weekty Zoom meeting were held for PF patients & monthly meeting for carers. Speakers from the Health
Boards & Nl Hospi￿ were invited to talk to attendees about issues relevant lo them including dealing with
fatigue. nutrition. dealing with stress & anxiety. and the ever popular relaxation taster session.
The number of Ambassadors increased during the year & an Ambassador Co-ordinator <T¥ustee)
appointed. Ambassadors liaise with and assist beneficiarie5 in their local area
d. Purchase of hand-held fan5 for distriblrtion to PF patients by clinicians.
Education
We attended numerous events where we were able to provide infom)ation to the public about Pulmonary Fibrosis
and PFNI. These ranged from ftjndraising events lo specialist Conferen￿$.
Our website is extensive and regulaity updated. We aim to support and supplement infomation prowded by
clinicians about PF and ensure that all information provided is accurate and Current by liaising with medical
professionals.
Flnanclal revlew
Annual Income
During the year the Charity generated incoming resource5 of £279.528.
All incomes were derived from personal or business donations and ftjndraising activities by our benefiaaries and
supporteT$.
Ann alE
enditure
Financially 2023124 was a satisfactory year for PFNI. Apart from costs associated with administration of the charity
all expenditure was in the fvrtheran￿ of the aims of the charity. All volLtnteers are entitted to receive oul-of-pocket
expenses. All volunteers are entitled to re￿1ve travel expenses for joumeys on offiaal business which are paid at a
standard rate accepted by HMRC as giving no personal gain to the recipient
Outgoing reSOur￿S were £30,145 leaving net incoming resources of £249.383 for the year to 31 March 2023.
Charity reserves should provide the organisation with adequate ffnancial stability and the means for it to meet ils
charitable objectives for the foreseeable future.
The Trustees retain fund5 in the Chartty to finance the ongoing running costs of the charity and to provide funds at
short notice lo finan￿ the objectives of Ihe charity.

PULMONARY FIBROSIS NI
TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY 2024
Plans for future periods
The Trustees of PFNI plan to=
a. Purchase a propety that is suitable for use all-year-round by even more PF patients. their carers &
families. that is disability friendly. and is located in an area thatls peaceful and relaxing for users.
Encourage the use of both properties by those living with PF to enjoy so rest and relaxation.
To continue lo build strong relationships with medical professionals.
g. To continue to build re131ionships with local, national and international communities, businesses & char4tie5
to improve and increase awareness & knowledge of PF & PFNI.
h. To provide events and activities to benefit the knowledge. mental health and wellbeing of our beneficiaries.
To identify areas where we can provide support for family members of PF patients. including children.
Structure, governance and management
The trustees. who are also the directors for the purpose of company law. and who served during the year and up to
the date of signature of the financial statements were-
T J Mcmillan
JMByme
M U Mcmillan
P M Gomian
I Simpson
Dr. N Chaudhuri
C J Donohoe
(Appointed 16 June 2023)
(Appointed 16 June 2023)
The trustee5' report was approved by the Board of Trustees.
I lyl B
.Jriic INOVJ
Trustee
2024 13."44 GMI Tl
28 November 2024

PULMONARY FIBROSIS NI
INDEPENDENT EXAMINER'S REPORT
TO THE TRUSTEES OF PULMONARY FIBROSIS NI
I report to the trustees on my examination of Ihe financial statements of Pulmonary Fibrosis Nl (the charity) for the
year ended 29 February 2024.
Responslbllltie$ and basis of report
As the Irustees of the char¢ly (and also ils directors for the purposes of company law} you are responsible for the
preparation of the financtal statements in accordan￿ with the requirements of the Companies Act 2006 (the 2006
Acll.
Havtng sab"sfied rnyself that the charity is not subject to audit under company law, and 1$ eligible for independent
examination. it is my responsibility to..
examine the aixounts under section 65 of the Charities Act
follow the procedures laid down in the general Diiections given by the Charity Commission for Northem
Ireland under section 65(9){bl of the Charities Act
State whether particular matters have come to my attention.
Independent examinerfs statement
Since the eharity's gross income exlxded £250.000 your examiner must be a member of a b¢Jdy listed in section
145 of the 2011 Act I confimi that l am qualified to undertake the examination because l am a member of Chartered
Accountants Ireland. which is one of the listed bodies.
I have examined your charity accounts as required under section 65 of the Charities Act and my examination was
carried out in accordan￿ with the general DirectTons given by the Charity Commission for Northern Ireland under
section 6519)(b} of the Charities Act. The examinatiorE induded a review of the accounting records kept by the
charity and a comparison of the accounts presented with those records. It also included consideration of any
unusual items or disclosuTes in the accounts. and seeking explanations from you as charity trustees concerning any
such matters. I confimi that no matters have ￿me to my attention in connection with the examination gimng me
cause to believe that in any material respect..
accounting records were not kept in respect of the charity as reqltired by section 386 of the 2006 Act., or
the financial statements do not accord with those records,- or
the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other
than any requirement that the accounts give a true and fair view which 15 not a matter considered as part of an
independent examination.. or
the financi81 statements have not begn prepared in accordance wtlh the methods and principles of the
Statement of Recommended Practi￿ for accounting and reporting by charities applicable to charities
preparing their accounts in ?￿ordanCe with the Financial Repoiting Standard applicable in the UK and
Republic of Ireland IFRS 102).
I have no cOn￿r￿S and have come across no other matters in connection with the examination to which attention
should be dlawn in this report in order lo enable a proper understanding of the financial statements lo be reached.
ko4
iuia Arinstronu INOV 28, 2024 17.'uO GlwlT)
PaLFla Armstrong
For and on behalf of MTS Prior Mcmahon
hartered Accountants
104-108 Fran¢es Street
Newtownards
Down
BT23 7DY
Dated.. 28 November 2024

PULMONARY FIBROSIS NI
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 29 FEBRUAR Y 2024
Unrestricted
funds
2024
Re$trl¢ted
funds
2024
Total
Unrestrlcted
funds
2023
2024
Note$
Income from:
Donations and legacies
Other trading activities
67,802
82,466
129.260
197,062
82.466
46.403
49.520
Total Income
150,268
129.260
279,528
95.923
Expenditure on:
Raising funds
Charitable 8ctivilie5
2,500
27.645
2.500
27,645
235
20.827
Total expenditure
30.145
30.145
21.062
Net income and movement in funds
120.123
129,260
249.383
74,861
Reconclllation of funds:
Fund balances at 1 March 2023
101,623
101,623
26.762
Fund balances at 29 February 2024
221,746
129.260
351.006
101.623
The statement of financial activities includes all gains and losses reeognised in the year. All incom& and expenditure
derive from continuing activities.

PULMONARY FIBROSIS NI
BALANCE SHEET
ASAT29 FEBRUARY2024
2024
2023
Notes
Flxod assets
Tangible assets
12
57.247
62.630
Current assets
Debtors
Cash at bank and in hand
13
2,000
292.539
41,338
294,539
41,338
Creditors: amounts falling due wtthin
one year
14
17801
{2,3451
Net current assets
293.759
38.993
Total assets less current liabilities
351.C106
101.623
Net assets excluding penslon liability
351.006
101.623
The funds of the charity
Restricted income funds
Unrestricted funds
15
129.260
221.746
101.623
351,(K)6
101,623
The company is enlilfed to the exemption from the audit requirement contained in section 477 of the Companies Act
2006. for the year ended 29 February 2024.
The directors acknowledge their responsibilitie5 for complying with the requirements of the Companie5 Act 2006
with respect to accounting records and the preparation of financial slatemenls.
The membets have not required the ¢ompany to obtain an audit of its financial statements for the year in que5ts.on In
accordance with section 476.
These financial statements have bèan prepared in accordance with tho promsions applicable to companies subject
to the small companies regime.
The financial statements were approved by the trustees on 28 November 2024
JudiLlI 1,-1 B yrite IN()v 3
JMByme
Trustee
1024 13..44 GN.1Tj
Company registrab'on number N1685604 (Northein Ireland)

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUAR Y 2024
Accounting policies
Charlty Infomiatlon
Pulmonary Fibrosis Nl is a private company limited by guarantee incorporated in Northem Ireland. The
registered office is 3 Churchfield Road. Ballycastle, BT54 6PJ. Northern Ireland.
1.1 Reporting perlod
This is the first period of attount.
1.2 Accounting convention
The financial statements have been prepared in accordan￿ with the charity's Igoverning documentl. the
Companies Act 2006. FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of
Ireland" I'FRS 102") and the Charities SORP "Accounting and Reporting by Charities.. Statement of
Recommerided Practice applicable to charities preparing their accounts in accordance with the Financial
Reporting Standard applicable in the UK and Republic of Iieland {FRS 1021" (effective l January 20191. The
¢harity is a Public Benefit Entity as defined by FRS 102.
The charty has taken advantage of the provisions in the SORP for charities not to prepare a Statement of
Cash Flows.
The financial ststements are prepared in sterting, which is the fvnclional currency of the Charity. Monetsry
amounts ill these financial statements are rounded lo ￿e nearest £.
The financial statements have been prepared under the historical cost convention. Imodified to indude the
revaluation of freehold properbes and to include investment properties and certain financial instruments at fair
valuel. The principal accounting policies adopted are set out below.
1.3 Going concem
At the time of appmving the financial statements. the trustee5 have a reasonable expe¢talion th81 the charity
has adequate resources to continue in operational existence for the foreseeable future. Thu5 the trustees
continue to adopt the going concem basis of accounting in preparing the financial statements.
1A Charitable funds
Unrestricted funds are available for vse at the discretion of the Irustees in furtherance of their tharitable
objectives.
Restricted fvnds are subject to $pe¢ifi¢ condibons by donors or grantors as to how they may be used. The
purpose5 and uses of the restricted funds are Set out in the note$ 1¢ the financial statements.
Endowment fvnds are subiect to specific conditions by donors that the capital must be maintained by the
charity.
1.5 Income
Income is recognised when the charity is legally entitled to Ét after any perfornian￿ conditsons have been met.
the amounts ¢an be measured reliably, and it is probable that incorne wll be received.
Cash donations are recogni$ed on r¢¢eipt. Other donations are recognised once the charity has been notlfied
of the donab'on, unless performance conditions require deferrel of the amount. Income tsx ie¢overable in
relation to donaty'ons received under Gift Aid or deeds of covenant is recognised at the lime of the donation.
Legacies are recognised on retsipt or otherwise if the charity has been notified of an impending distribution,
the amount is known, and receipt Is expected. If the amount is not known, the tegacy is treated as a
contingent asseL

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUAR Y 2024
Accounting pollcles
(Continued)
1.6 Expendlture
Expenditure is recognised once there is a legal or constructive obligation to transfer e¢onomic benefit lo a
third paty, it is probable that a transfer of economic benefits will be required in setttement, and the amount of
the obligation can be measured reliably.
Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and
shared costs, including support costs involved in undertaking each actiwty. Direct costs attribLttable to a single
activity are allocated directly lo that activity- Shared costs which contribute to more than one activ*ty and
support costs which are not attributable to a single activÈly a￿ apporboned be￿een those activits.es on a basis
consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and
depreGtation char9es are allocated on the portion of the asset'5 use.
1.7 Tanglble fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valualion. net of
depreciation and any impairment losses.
Depreciation is recognised $0 as to write off thè Cost or valuation of assets les$ their residual values over their
usefvl lives on the following bases..
Puffin Lodge
Fixtures and fittings
Computers
10Yo Reducing balan
20¥0 Reducing balance
25% Straight line
The gain or loss arising ori the disposal of an asset is determined as the difference belween the sale pioceeds
ar2d the carying value of the asse( and is recognised in the statement of financial ackn-vibes.
1.8 ImpaiFment of tixed assets
At each reporting end date. the charity reviews the carying amounts of its tangible assets to determine
whether there is any indication that those assets have suffered an impairment loss. If any such indication
exists. the recoverable amount of the asset is estimated in order to delemiine the extent of the impaiment
loss (if any).
1.9 Cash and ea$h equivalents
Cash and cash equivalents include eash in hand, deposits held at call with banks. other short-tem liquid
investments with original matuiities of three months or less. 8nd bank overdrafts. Bank overdrafts are shown
within borrowings in current liabilities.
1.10 Financial instrument5
The tharity has elected to apply the provisions of Section 11 'Basic Financial lrtslruments, and Section 12
'Other Finanual Instruments Issues, of FRS 102 to all of its financial instnjments.
Financial instruments are recognised in the ¢harity's balan￿ sheet when the charity becomes paty lo the
contractual provisions of the instrumenL
Financial assets and liabilitie3 are offset, with the net amounts presented in the financial stalemenls. when
there is a legally enforceable ruht to Sel off the recognised amounts and there is an intention to settle on a net
basis or to realise the as5el and settle the liability simultaneously.

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY 2024
Accounting policies
(Continuod)
Basle financlal assets
Basic financial assets. whieh include debtors and cash and bank balances. are initially measured at
transaction price including transaction costs and are subsequently carried at amortised cost using the effective
interest method unless the arrangement constitijtes a financing transaction, where the transaction is
measured at Ihe present value of the luture receipts discounted at a market rale of interest. Financial assets
dassified as receivable within one year are not amortised.
Basie fiTnancial liabilities
Basic financial liabilities. including creditors and bank loans are initially recognised at transaction price unless
the arrangement constitutes a finallcing transaction. where the debt instrument is measured at the present
value of the future payments discounted at a market rate of interest. Financial liabiltties dassified as payable
within one yeaT are not amort15ed.
Debt inslTument5 are Subsequently carried at amortised cost. using the effective intsrest rate method.
Trade creditors are obligations to pay for goods or serv¢ces that have been acquired in the ordinary course of
operattons from suppliers. Amounts payable are classified as current liabilits"e5 if payment is due within one
year or les5. If not. they are presented as non-current liabilities. Trade creditors are recognised inib.ally at
transaction price and subsequently measured at amortised cost using the effecb've interest method.
Dereeognition of financlal Ilabllftles
Financial liabilities are derecognised when the charity's contractual obligations expire or are dischaiged or
cancelled.
1.11 Employee benofits
The cost of any unused holiday entitlement is recognised in the period in which the employee's services are
received.
Termination benefits are recognised immediately as an expense when the charity is demonstrably committed
to terminate the employment of an employee or to provide termination beneffts.
Critical accounting estimates and Judgements
In the application of the charity's accounb-ng policies. the trustees are required to make judgements. esb'mates
and assumptions about the carying amount of assets and liabilities that are not readity apparent from other
SoUr￿s. The estimates and associated assumptions are based on historic81 experien* and other factors that
are conside￿d to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions lo a¢¢ounting
estimates are recognised in the pèriod in which the estimate is remsed where the revision affects only that
period, or in the period of the revision and fijture period5 Whe￿ the Tevision affects both ¢urrenl and futsjre
periods.
Income from donations and legacles
Unrestricted Restrl¢ted
funds
funds
2024
2024
Total Unre9trfcted Reslri¢ted
fund$
funds
2023
2023
Total
2024
2023
Donations and gifts
67,802
129,260
197,062
46,403
46.403
10-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY2024
Income from other trading actlvltles
Unrestrlcted Unrestrlcted
funds
funds
2024
2023
Fundraising events
82,466
49,520
Expenditure on raising fund$
Unrestricted Unrestricted
funds
funds
2024
2023
Fundraising and publicity
Support costs
2.500
235
Expènditure on charitable activities
Heading
#ac982
2024
Heading
*ac982
2023
Dlre¢t costs
Depreciation and impaimieTrt
Insurance
Puffin lodge costs
Office expenses
General expenses
Postage
Computer & website costs
Telephone
Printing
Travel & Accommodation
7.341
897
7.195
3,711
529
5,274
654
2.569
184
2.742
177
2.687
707
191
918
90
2,608
2,200
Member Gifts & Services
3,885
26.032
18,527
Share of support and governance ¢o$ts l$eg note 7)
Govemance
1.613
2,300
27,645
20.827
Analysls by fund
Unreslricled funds
27,645
20,827
11

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY2024
Support costs allocated to activities
2024
2023
Fundraising
Goveman¢e costs
2,500
1,613
235
2.300
4,113
2.535
Analysod between:
Fundraising
Professional Fees
2,500
1.613
235
2.300
4.113
2.535
Net rnovement sn funds
2024
2023
The net movement in fvnds is slated after chargingl{crediting)'.
Depreciation of owned tangible fixed assets
7,341
3.711
Trustees
None of the trustees (or any persons connected with them) re￿iVed any remuneration or benefits from the
charity during the year.
10 Employees
The average monthly number ofemployees during the year was..
2024
Number
2023
Number
Total
There wgre no employees whose annual remuneration was more than £60.000.
Remunarotion of key management personnel
The remuneration of key management personnel was as follows..
11 Taxation
The charity is exempl from taxation on its activities because all its income is applied for charitable purposes.
12-

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUAR Y 2024
12 Tangible fixed assets
Puffln Lodge Flxturas and
fittings
Computers
Total
Cost
At 1 March 2023
Additions
61,199
3,873
1,269
1.958
66.341
1.958
At 29 Febfuary 2024
61,199
3,873
3.227
68,299
Depreciation and Impalmient
At 1 March 2023
Depre¢iation charged in the year
3,060
5.814
387
863
264
664
3,711
7,341
At 29 February 2024
8,874
1.250
928
11.052
Carrying amount
At 29 February 2024
52,325
2,623
2.299
57,247
At 28 February 2023
58.139
3.486
1.005
62,630
13 Debtors
2024
2023
Amounts falling due within one year-
Prepayments and accrued income
2.000
14 Creditors- amounts falling due within one year
2024
2023
Other creditors
Accruals and deferred income
45
2.3(10
780
780
2,345
15 Restricted funds
The restricted funds of the Charlty Comprise the unexpended balan￿$ of donations and grants held on trust
Subject to specific ¢onditions by donors as to how they may be used.
At 1 March
2023
Incomlng
At29
resources February 2024
129,260
129,260

PULMONARY FIBROSIS NI
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY2024
16 Unrestrlcted funds
The unrestricted fttnds of the charity comprise the unexpended balances of donations and grants which are
not subject to specific conditions by donors and grantors as to how they may be used. These include
designated funds which have been set aside out of unrestricted fund5 by the trustees for specific purposes.
At l March
2023
Incoming
resources
Resources
At29
expended February 2024
General funds
101,623
150.268
(30.145)
221,746
Previous period:
At 1 Marth
2022
Incoming
resources
Resources
At28
expended February 2023
General funds
26,762
95.923
{21.062)
101,623
17 Analysis of net assets between funds
Unrestricted
funds
2024
Restricted
funds
2024
Total
2024
At 29 February 2024:
Tangible assets
Current assetsl{liabilities)
57,247
164.499
57,247
293.759
129.260
221,746
129.260
351.006
Unrestricted
funds
2023
Restricted
funds
2023
Total
2023
At 28 February 2023:
Tangible assets
Current assetsl{liabilitiesl
62,630
38.993
62,630
38,993
101,623
101,623
18 Related party transactlons
There were no disclosable related party transactions during the year (2023 - none).
14-